ArticleCirculation research2026

Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Laura Lalaguna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.